Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susumu Hirota"'
Autor:
Tadashi Kato, Toshi A. Furukawa, Akio Mantani, Ken’ichi Kurata, Hajime Kubouchi, Susumu Hirota, Hirotoshi Sato, Kazuyuki Sugishita, Bun Chino, Kahori Itoh, Yoshio Ikeda, Yoshihiro Shinagawa, Masaki Kondo, Yasumasa Okamoto, Hirokazu Fujita, Motomu Suga, Shingo Yasumoto, Naohisa Tsujino, Takeshi Inoue, Noboru Fujise, Tatsuo Akechi, Mitsuhiko Yamada, Shinji Shimodera, Norio Watanabe, Masatoshi Inagaki, Kazuhira Miki, Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Aran Tajika, Kiyomi Shinohara, Naohiro Yonemoto, Shiro Tanaka, Qi Zhou, Gordon H. Guyatt, for the SUN☺D Investigators
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background For patients starting treatment for depression, current guidelines recommend titrating the antidepressant dosage to the maximum of the licenced range if tolerated. When patients do not achieve remission within several weeks, recom
Externí odkaz:
https://doaj.org/article/5e4bf872a44f43d48738e1d04187f28b
Publikováno v:
Journal of clinical psychopharmacology. 42(4)
Lamotrigine (LTG) is used for treatment of mood disorders, but it is associated with the risk of rash occurrence in the initial administration phase. Although slow titration reduces this risk, its effectiveness in the treatment of mood disorders has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d69997e0404c15658a747edb2476158
https://pubmed.ncbi.nlm.nih.gov/35506599
https://pubmed.ncbi.nlm.nih.gov/35506599
Autor:
Sund Investigators, Akio Mantani, Shinji Shimodera, Tatsuo Akechi, Kenichi Kurata, Norio Watanabe, Susumu Hirota, Tadashi Kato, Mitsuhiko Yamada, Toshi A. Furukawa, Masatoshi Inagaki
Publikováno v:
Journal of affective disorders. 250
Background Identifying the predictors of relapse could help to develop more individualized treatment strategies for major depression. The study aim was to explore predictors of depression relapse after remission using data from our previous multicent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e2091bb3fc1140c44d48d7359311706
https://pubmed.ncbi.nlm.nih.gov/30851699
https://pubmed.ncbi.nlm.nih.gov/30851699
Autor:
Tadashi Kato, Toshi A. Furukawa, Akio Mantani, Ken’ichi Kurata, Hajime Kubouchi, Susumu Hirota, Hirotoshi Sato, Kazuyuki Sugishita, Bun Chino, Kahori Itoh, Yoshio Ikeda, Yoshihiro Shinagawa, Masaki Kondo, Yasumasa Okamoto, Hirokazu Fujita, Motomu Suga, Shingo Yasumoto, Naohisa Tsujino, Takeshi Inoue, Noboru Fujise, Tatsuo Akechi, Mitsuhiko Yamada, Shinji Shimodera, Norio Watanabe, Masatoshi Inagaki, Kazuhira Miki, Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Aran Tajika, Kiyomi Shinohara, Naohiro Yonemoto, Shiro Tanaka, Qi Zhou, Gordon H. Guyatt, for the SUN☺D Investigators
Publikováno v:
BMC Medicine
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Background For patients starting treatment for depression, current guidelines recommend titrating the antidepressant dosage to the maximum of the licenced range if tolerated. When patients do not achieve remission within several weeks, recommendation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9c3130f2a1ea3dfe46f15567443812
https://pubmed.ncbi.nlm.nih.gov/29991347
https://pubmed.ncbi.nlm.nih.gov/29991347
Autor:
Koji Miki, Yoshio Hoaki, Taketoshi Matsuki, Nobuyuki Hattori, Kazutoyo Inanaga, Akira Shigemoto, Susumu Hirota, Nobuhiro Mori
Publikováno v:
Personalized Medicine Universe. 3:49-53
Nerve growth factor (NGF) is considered as a very promising candidate in the treatment of Alzheimer’s disease [1]. However, NGF is a protein that becomes inactive after oral administration. A breakthrough in treatment occurred with the discovery of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3121652338b3228ef06a55f3d44cbee
https://doi.org/10.1016/j.pmu.2014.04.002
https://doi.org/10.1016/j.pmu.2014.04.002
Autor:
Wei Yao, Kazutoyo Inanaga, Ji-chun Zhang, Chao Dong, Cun Zhuang, Kenji Hashimoto, Susumu Hirota
Publikováno v:
Pharmacology, biochemistry, and behavior. 136
Accumulating evidence suggests that inflammation plays a role in the pathophysiology of depression and that anti-inflammatory substances have antidepressant effects. Amycenone is obtained from extracts of the Yamabushitake (Hericium erinaceum). The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454948dd0567278b846ccbf8c985ec32
https://pubmed.ncbi.nlm.nih.gov/26150007
https://pubmed.ncbi.nlm.nih.gov/26150007